Bliss GVS Pharma Ltd. (BLISSGVS-BE): Bliss GVS Pharma Share Price hits fresh 52-week high at Rs 603.7
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Bliss GVS Pharma Share Price rose to Rs 603.7, up 2.84% today, and touched a fresh 52-week high of Rs 616.4. The company’s market capitalisation stands at Rs 6,238.89 crore. This move places Bliss GVS Pharma Ltd. (BLISSGVS-BE) in focus in Bliss GVS Pharma Stock News and Bliss GVS Pharma Share Price Today coverage. The verified data confirms a new yearly high, but it does not establish a company-specific catalyst. For readers tracking Bliss GVS Pharma Share Price, the event matters because it combines a higher close than the previous session with a fresh price peak and measurable valuation context that Univest can track through price, fundamentals and peer benchmarks.
Bliss GVS Pharma Share Price also matters from a market update perspective because the stock opened at Rs 590, traded between Rs 577 and Rs 616.4, and finished above its previous close of Rs 587.05. The day change of Rs 16.65 is factual price movement, while the 52-week high confirms a one-year high event. Univest is covering the stock as part of broader Bliss GVS Pharma News Today and market news flows, with the focus on verified numbers rather than assumptions about why the move occurred.
Bliss GVS Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 603.7 |
| Previous Close | Rs 587.05 |
| Today's Move | +Rs 16.65 (+2.84%) |
| Open | Rs 590 |
| High | Rs 616.4 |
| Low | Rs 577 |
| Turnover | Rs 0.55 crore |
| Market Capitalisation | Rs 6,238.89 crore |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 603.7 versus the previous close of Rs 587.05, a rise of 2.84%. The stock opened at Rs 590, reached a high of Rs 616.4 and touched a low of Rs 577.
Bliss GVS Pharma Share Price Today shows a straightforward session with a higher close, a fresh 52-week high and a close near the day’s upper end. The stock opened at Rs 590, moved through an intraday low of Rs 577, and reached Rs 616.4, which also marked the 52-week high. It settled at Rs 603.7, above the previous close of Rs 587.05 by Rs 16.65, or 2.84%. Turnover stood at Rs 0.55 crore.
The key facts are the gap between the previous close and the current price, plus the fact that the day’s high matched the yearly peak. That makes Bliss GVS Pharma Share Price relevant in stock market today screens and 52 Week High Stocks lists. The data supports a clear price action update, but it does not establish a company-specific catalyst. For readers following Bliss GVS Pharma Share News, the session is notable because the stock closed above the prior day’s level and printed a new one-year high in the same session.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,238.89 crore |
| P/E Ratio | 45.81x |
| P/B Ratio | 5.06x |
| ROE | 12.11% |
| ROCE | 17.4% |
| EPS | Rs 12.81 |
| Book Value Per Share | Rs 116 |
| Dividend Yield | 0.26% |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) fundamental metrics show P/E 45.81x, P/B 5.06x, ROE 12.11%, ROCE 17.4%. These figures provide context only and are not a buy or sell signal.
Bliss GVS Pharma Ltd. has a market capitalisation of Rs 6238.89 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 45.81x, P/B at 5.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.11% and ROCE of 17.4%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 12.81, book value per share of Rs 116, dividend yield of 0.26%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.12x, median ROE of 11.78%, median ROCE of 13.59%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 45.81x |
| Benchmark Median P/E | 31.12x |
| Benchmark Average P/E | 48.12x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 5.06x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 12.11% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 17.4% |
| Benchmark Median ROCE | 13.59% |
| Company Market Capitalisation | Rs 6,238.89 crore |
| Benchmark Median Market Cap | Rs 630.79 crore |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 45.81x, which is above the benchmark median of 31.12x, a difference of +47.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of 12.11%, which is above the benchmark median of 11.78%, a difference of +2.8%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 17.4%, which is above the benchmark median of 13.59%, a difference of +28.04%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Innova Captab Ltd. | INNOVACAP | 6,036.37 | 38.62 | 5.32 | 13.75 | 15.04 |
| Supriya Lifescience Ltd. | SUPRIYA | 6,468.81 | 32.61 | 5.29 | 20.74 | 27.63 |
| Orchid Pharma Ltd. | ORCHPHARMA | 5,827.43 | 672.45 | 4.48 | 7.86 | 8.05 |
| Morepen Laboratories Ltd. | MOREPENLAB | 5,819.82 | 41.41 | 4.47 | 11.78 | 15.48 |
| IOL Chemicals And Pharmaceuticals Ltd. | IOLCP | 5,717.92 | 34.01 | 3.07 | 7.9 | 10.65 |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 45.81x compared with the displayed peer median of 38.62x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.11% compares with a peer median of 11.78% across the companies shown in the table. ROCE stood at 17.4% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 6,238.89 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Bliss GVS Pharma
- Bliss GVS Pharma Share Price closed at Rs 603.7 after rising 2.84% from the previous close of Rs 587.05.
- The stock printed a fresh 52-week high of Rs 616.4 during the session.
- Market capitalisation stands at Rs 6,238.89 crore.
- P/E is 45.81 and P/B is 5.06, both above the industry median in the supplied benchmark.
- ROE is 12.11% and ROCE is 17.4%, both higher than the benchmark medians in the same industry set.
About Bliss GVS Pharma
Bliss GVS Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company data shows a recent financial track with revenue moving from Rs 2,074.69 crore in Jun 2025 to Rs 2,855.76 crore in Jun 2026, while net profit increased from Rs 430.38 crore to Rs 500.97 crore over the same period. Bliss GVS Pharma Share Price is therefore being tracked not only as a fresh 52-week high event but also as a stock with measurable operating and valuation data. For Univest readers, that combination keeps Bliss GVS Pharma Stock News relevant in both market news and fundamental analysis discussions.
Track Bliss GVS Pharma Share Price on Univest
Use Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Bliss GVS Pharma Share Price on Univest to review live price updates, fundamental ratios, shareholding pattern, 52-week levels, sector context and market insights in one place. Univest brings together price action, valuation and company data for faster stock monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Bliss GVS Pharma Share Price hit a fresh 52-week high?
Ans. The supplied data confirms that Bliss GVS Pharma Share Price reached Rs 616.4 during the session and closed at Rs 603.7. It confirms the price event, but it does not establish a company-specific catalyst.
What is Bliss GVS Pharma Share Price today?
Ans. Bliss GVS Pharma Share Price today is Rs 603.7, after a rise of Rs 16.65 or 2.84% from the previous close of Rs 587.05. The session also marked a fresh 52-week high.
What is the 52-week high for Bliss GVS Pharma?
Ans. The fresh 52-week high for Bliss GVS Pharma is Rs 616.4. The stock also opened at Rs 590 and traded as low as Rs 577 before settling at Rs 603.7.
How expensive is Bliss GVS Pharma Share Price on valuation metrics?
Ans. Bliss GVS Pharma trades at a P/E of 45.81 and a P/B of 5.06. Both are above the benchmark industry medians of 31.12 and 2.87 in the supplied sector snapshot.
How do Bliss GVS Pharma profitability metrics compare with the sector benchmark?
Ans. Bliss GVS Pharma reports ROE of 12.11% and ROCE of 17.4%. Both are above the benchmark medians of 11.78% and 13.59%, which adds factual context to the stock’s current market pricing.
